866-997-4948(US-Canada Toll Free)

Idiopathic Short Stature Global Clinical Trials Review, H2, 2017

Published By :

GlobalData

Published Date : Oct 2017

Category :

Pharmaceutical

No. of Pages : 52 Pages

Idiopathic Short Stature Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, Idiopathic Short Stature Global Clinical Trials Review, H2, 2017" provides an overview of Idiopathic Short Stature clinical trials scenario. This report provides top line data relating to the clinical trials on Idiopathic Short Stature. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalDatas proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Idiopathic Short Stature to Hormonal Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Idiopathic Short Stature to Hormonal Disorders Clinical Trials 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Idiopathic Short Stature Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 50
Abbreviations 50
Definitions 50
Research Methodology 51
Secondary Research 51
About GlobalData 52
Contact Us 52
Source 52

List of Tables
Idiopathic Short Stature Therapeutics, Global, Clinical Trials by Region, 2017* 6
Idiopathic Short Stature Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Idiopathic Short Stature Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Idiopathic Short Stature Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
Idiopathic Short Stature Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Idiopathic Short Stature Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Idiopathic Short Stature Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Idiopathic Short Stature Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 14
Proportion of Idiopathic Short Stature to Hormonal Disorders Clinical Trials, G7 Countries (%), 2017* 15
Idiopathic Short Stature Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Idiopathic Short Stature Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Idiopathic Short Stature to Hormonal Disorders Clinical Trials, E7 Countries (%), 2017* 18
Idiopathic Short Stature Therapeutics, Global, Clinical Trials by Phase, 2017* 19
Idiopathic Short Stature Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 20
Idiopathic Short Stature Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Idiopathic Short Stature Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Idiopathic Short Stature Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 24
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27

List of Figures
Idiopathic Short Stature Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Idiopathic Short Stature Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Idiopathic Short Stature Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Idiopathic Short Stature Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
Idiopathic Short Stature Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Idiopathic Short Stature Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Proportion of Idiopathic Short Stature to Hormonal Disorders Clinical Trials, G7 Countries (%), 2017* 15
Idiopathic Short Stature Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Idiopathic Short Stature Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Idiopathic Short Stature to Hormonal Disorders Clinical Trials, E7 Countries (%), 2017* 18
Idiopathic Short Stature Therapeutics, Global, Clinical Trials by Phase (%), 2017* 19
Idiopathic Short Stature Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 20
Idiopathic Short Stature Therapeutics, Global, Clinical Trials by Trial Status, 2017* 21
Idiopathic Short Stature Therapeutics Clinical Trials, Global, by End Point Status, 2017* 22
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 23
Idiopathic Short Stature Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 24
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 25
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 26
Idiopathic Short Stature Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 27
GlobalData Methodology 51

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *